pyrazines has been researched along with 7-methyl-5-(1-((3-(trifluoromethyl)phenyl)acetyl)-2,3-dihydro-1h-indol-5-yl)-7h-pyrrolo(2,3-d)pyrimidin-4-amine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chevet, E; Chintha, C; Darawshi, O; Eriksson, LA; Huber, M; Mahameed, M; Obiedat, A; Samali, A; Schubert, T; Tirosh, B; Tommy, WS; Wilhelm, T | 1 |
1 other study(ies) available for pyrazines and 7-methyl-5-(1-((3-(trifluoromethyl)phenyl)acetyl)-2,3-dihydro-1h-indol-5-yl)-7h-pyrrolo(2,3-d)pyrimidin-4-amine
| Article | Year |
|---|---|
The unfolded protein response modulators GSK2606414 and KIRA6 are potent KIT inhibitors.
Topics: Adenine; Cell Survival; eIF-2 Kinase; Endocytosis; HEK293 Cells; Hep G2 Cells; Humans; Imidazoles; Indoles; Kinetics; Lysosomes; Naphthalenes; Proto-Oncogene Proteins c-kit; Pyrazines; Unfolded Protein Response | 2019 |